Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
11 hedge funds and large institutions have $942K invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$259K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$87.6K |
| 3 |
Walleye Capital
New York
|
+$75.6K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$39.2K |
| 5 |
TCM
Tenor Capital Management
New York
|
+$39.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
AQR Arbitrage
Greenwich,
Connecticut
| $285K | +$259K | +396,056 | New |
|
|
DAM
2
Decagon Asset Management
London,
United Kingdom
| $160K | +$119K | +181,986 | New |
|
|
SCM
3
Shaolin Capital Management
Miami,
Florida
| $118K | +$87.6K | +134,000 | New |
|
|
4
Walleye Capital
New York
| $102K | +$75.6K | +115,616 | New |
|
|
GAM
5
Gritstone Asset Management
Bethesda,
Maryland
| $70.3K | +$52.3K | +79,999 | New |
|
|
ECM
6
ExodusPoint Capital Management
New York
| $53K | +$39.2K | +60,000 | New |
|
|
TCM
7
Tenor Capital Management
New York
| $52.7K | +$39.2K | +60,000 | New |
|
|
SC
8
Sculptor Capital
New York
| $36.3K | +$32.7K | +50,000 | New |
|
|
KPF
9
K2 Principal Fund
Toronto,
Ontario, Canada
| $34.4K | +$25.5K | +39,058 | New |
|
10
Verition Fund Management
Greenwich,
Connecticut
| $29.9K | +$22.3K | +34,050 | New |
|
|
CS
11
Clear Street
New York
| $816 | +$607 | +929 | New |
|
|
HCM
12
Highbridge Capital Management
New York
| $88 | – | – | – |
|
OACCW Hedge Fund Activity: Q4 2024 in Review
11 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q4 2024, worth a combined $942K.
Buyers outnumbered sellers: 11 funds opened new OACCW positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $259K.
- 11 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $942K of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q4 2024.
- 11 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q4 2024 and 0 closed out, a net change of +11 holders.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q4 2024 was AQR Arbitrage, an estimated $259K added.
Based on aggregated 13F filings for Q4 2024.